683 Capital Management’s Eli Lilly LLY Stock Holding History

683 Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$185M	Buy	154,000 +20,000	+15%	+$20.4M	9.07%	2
2026 Q1	$123M	Sell	134,000 -20,000	-13%	-$20.3M	6.43%	2
2025 Q4	$166M	Buy	154,000 +4,000	+3%	+$3.82M	7.2%	2
2025 Q3	$114M	Buy	150,000 +45,000	+43%	+$33.5M	5.98%	2
2025 Q2	$81.9M	Sell	105,000 -10,000	-9%	-$7.77M	5.38%	3
2025 Q1	$95M	Sell	115,000 -115,000	-50%	-$95.7M	6.55%	1
2024 Q4	$178M	Buy	230,000 +30,000	+15%	+$24.8M	11%	2
2024 Q3	$177M	Buy	200,000 +9,000	+5%	+$8.09M	13.48%	1
2024 Q2	$173M	Buy	191,000 +40,000	+26%	+$32M	13.07%	1
2024 Q1	$117M	Buy	+151,000	New	+$107M	8.6%	1

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

683 Capital Management's LLY Position: Q2 2026 in Review

683 Capital Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 15,000 shares — an estimated $15.3M sold.

683 Capital Management first reported a position in LLY in Q1 2025 and held it in 4 quarters. The position peaked at $17.4M in Q3 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

683 Capital Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
683 Capital Management sold 15,000 Eli Lilly shares in Q2 2026, an estimated $15.3M.
683 Capital Management first reported a position in Eli Lilly in Q1 2025 and held it in 4 quarters.
683 Capital Management's Eli Lilly position peaked at $17.4M in Q3 2025.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.